A Randomized, Open Label, Four Period, Cross-Over Study to Evaluate the Pharmacokinetics of Single Doses of Various TRV734 Formulations in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2015
At a glance
- Drugs TRV 734 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Trevena
- 17 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2015 According to a Trevena media release, data from this trial are expected later this year.
- 14 Apr 2015 New trial record